Wimmi, Stephan - CAP 48

Deciphering the spatial-temporal regulation of type IV secretion-mediated bacterial killing and antibiotic efflux pumps in Stenotrophomonas maltophilia

Dr. Stephan Wimmi
Dr. Stephan Wimmi

Institute for Biological Physics, MNF

CMMC - PI - CAP 48

Institute for Biological Physics, MNF

Zülpicher Str. 47a

50674 Cologne

Introduction

Stenotrophomonas maltophilia is a rising opportunistic bacterial human pathogen. It is omnipresent in the environment and considered a low-virulence pathogen. Nevertheless, in immunocompromised patients and especially in the hospital setting, it causes a wide range of infections. Here, its intrinsic multidrug resistance, facilitated by numerous antibiotic efflux pumps and frequent coinfections with other pathogens like e.g. Pseudomonas aeruginosa, makes it an increasing health threat. One of S. maltophilia's major pathogenicity factors is a Type IV Secretion system (T4SS). This is not only deployed against human epithelial and immune cells during an infection, but also causes contact-dependent cell death in a wide range of bacterial human pathogens, including Salmonella Typhi, and at least two ESKAPE bacteria (Klebsiella pneumoniae and Pseudomonas aeruginosa). By investigating the function, regulation, and response of the T4SS, with a combination of molecular biology, microscopy, and biochemistry, we aim to understand what makes the T4SS such a key tool to establish a local niche during an infection.

Aims

Within the CMMC and with the CAP program, we want to study S. maltophilia and to understand which molecular processes allow it to colonize its local niche and cause an infection. To do so, we focus on the T4SS depended bacterial killing and antibiotic efflux pumps and investigate their function, regulation, and response to different environmental cues using a combination of molecular microbiology, biochemistry, and biophysical methods.  

Clinical Relevance

S. maltophilia is an opportunistic human pathogen with a global environmental distribution. In the clinical context, it's often acquired via nosocomial and community-acquired infections in immunocompromised patients. Here, it presents with a wide range of disease patterns, a high intrinsic antibiotic resistance, and a substantial mortality rate. Its T4SS is one of its central pathogenicity factors and has been shown to have anti-apoptotic effects on human lung epithelial cells while at the same time inducing apoptosis in macrophages. In addition, the T4SS has been shown to kill off competing Gram-negative bacteria like K. pneumonia, Salmonella Typhi, and P. aeruginosa in a contact-dependent manner. Overall, dissecting the impact of S. maltophilias T4SS on infections and competition will bring us closer to understanding and combating infections with this already multi-resistant human pathogen.

2026

Publications will be listed as soon as available.